Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods

Gelijkaardige items

• Erratum for Hernández et al., “Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Epidemic and Nonepidemic Influenza Periods”
  door: Hernández, Sergi, et al.
  Gepubliceerd in: (2020)
• Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
  door: Domínguez, Ángela, et al.
  Gepubliceerd in: (2017)
• Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
  door: Izquierdo, C., et al.
  Gepubliceerd in: (2020)
• Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain
  door: Hernández, Sergi, et al.
  Gepubliceerd in: (2020)
• Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
  door: Ludwig, Guillermo, et al.
  Gepubliceerd in: (2020)